Myomo Inc (MYO) Short Interest Update
Myomo Inc (NYSEAMERICAN:MYO) was the target of a large drop in short interest in January. As of January 31st, there was short interest totalling 545,305 shares, a drop of 10.3% from the January 15th total of 608,064 shares. Based on an average daily volume of 47,869 shares, the days-to-cover ratio is currently 11.4 days. Currently, 5.3% of the company’s stock are sold short.
An institutional investor recently raised its position in Myomo stock. Bank of New York Mellon Corp increased its position in Myomo Inc (NYSEAMERICAN:MYO) by 87.7% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 46,925 shares of the company’s stock after acquiring an additional 21,925 shares during the quarter. Bank of New York Mellon Corp owned about 0.38% of Myomo worth $68,000 at the end of the most recent quarter.
A number of research analysts have recently weighed in on the stock. Roth Capital restated a “buy” rating on shares of Myomo in a report on Tuesday, February 5th. Zacks Investment Research downgraded shares of Myomo from a “hold” rating to a “sell” rating in a report on Wednesday, November 14th.
TRADEMARK VIOLATION NOTICE: This story was first posted by Watch List News and is the property of of Watch List News. If you are reading this story on another website, it was illegally stolen and republished in violation of U.S. and international copyright & trademark legislation. The original version of this story can be viewed at https://www.watchlistnews.com/myomo-inc-myo-short-interest-update/2819116.html.
Myomo Company Profile
Myomo, Inc, a commercial stage medical robotics company, designs, develops, and produces myoelectric braces or orthotics for people suffering with neuromuscular disorders in the United States. It offers MyoPro, a powered upper limb orthosis that supports the arm, as well as restores function to the weakened or paralyzed arms of patients suffering from CVA stroke, brachial plexus injury, traumatic brain injury, spinal cord injury, ALS, or other neuromuscular disease or injury.
See Also: What Are Treasury Bonds?
Receive News & Ratings for Myomo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Myomo and related companies with MarketBeat.com's FREE daily email newsletter.